Needlestick reduction: Switching from user-activated safety devices to VanishPoint® automated retraction syringes cut contaminated needlestick injuries by 50% in the first year and achieved a zero percent contaminated needlestick rate in approximately two years of implementation.
Pilot results: Following a pilot by frontline users, the decision was made to implement VanishPoint syringes in all locations. The rollout revealed that user-activated devices left gaps in protection, while VanishPoint eliminated incidents except at one site that delayed adoption.
Staff acceptance: Nurses and clinical staff overwhelmingly favored the retractable syringes, reporting they were safer, easier to use, and preferable to previous devices.
Training and rollout: Structured education and phased adoption across 35 locations were essential in overcoming initial hesitation and ensuring consistent safe use.
Broader implications: The project demonstrated that organizational commitment, education, and staff engagement are critical to successfully implementing new sharps safety technologies.
Conclusion: Passive, automated retraction devices like VanishPoint provided a decisive improvement over user-activated safety systems, protecting both staff and patients while setting a strong precedent for sharps safety in healthcare networks.